Global Radiopharmaceuticals Market is Poised to Grow At 8.7% Till 2024

1
Global Radiology Information Systems Market
Global Radiopharmaceuticals Market is Poised to
Grow At 8.7 Till 2024
According to Data Bridge Market Research new
Market report Global Radiopharmaceuticals
Market, By Type (Diagnostic, Therapeutic),
Procedural Volumes (Diagnostic Procedures,
Therapeutic Procedures), Application, Sources
(Nuclear Reactors, Cyclotrons), End User,
Geography (North America, Europe, APAC, South
America, MEA)Industry Trends and Forecast To
2024? is projected to reach USD 9.49 billion by
2024 from USD 4.87 billion in 2016, at a CAGR of
8.7 in the forecast period 2017 to 2024. The new
market report contains data for historic years
2015, the base year of calculation is 2016 and
the forecast period is 2017 to 2024.
Browse Full Report and Details TOC https//databr
idgemarketresearch.com/reports/global-radiology-in
formation-systems-ris-market
2
Report Segmentation

• Global Radiology Information Systems (RIS)
  Market - Industry Trends and Forecast to
  2017-2024
• The Global Radiopharmaceuticals Market is
  segmented based on type, procedural volumes,
  application, sources, end-user, and geography.
• On the basis of type, the radiopharmaceuticals
  market is sub-segmented into diagnostic and
  therapeutic radiopharmaceuticals.
• On the basis of procedural volumes, the
  radiopharmaceuticals market is sub-segmented into
  diagnostic procedures and therapeutic procedures.
• On the basis of application, the global
  radiopharmaceuticals market is sub-segmented into
  diagnostic application and therapeutic
  application.

Request For Free Sample Report
https//databridgemarketresearch.com/request-a-sa
mple/?dbmrglobal-radiology-information-systems-ri
s-market
3
Recent Developments
Radiopharmaceuticals are mostly used for
treatment of cancer, bone pain, and thyroid
cancer. In the U.S. cancer is second fatal
disease whereas in the UK it is the leading cause
of death. In most of the third world countries
cancer appears much lower. Cancer is the second
leading cause of death globally and was
responsible for 8.8 million deaths in 2015.
Globally, nearly 1 in 6 deaths is due to cancer.
In 2016, an estimated 1.6 million new cases of
cancer was diagnosed in the United States and 0.5
million people died from the disease.
Speak to Expert https//databridgemarketresearch
.com/speak-to-analyst/?dbmrglobal-radiology-infor
mation-systems-ris-market
4
Major Players

• Cardinal Health Inc.
• MallinckrodtPlc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• CovidienPlc
• Positron Corporation

Inquiry Before Buying https//databridgemarketr
esearch.com/inquire-before-buying/?dbmrglobal-rad
iology-information-systems-ris-market
5
About-Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam1-888-387-2818 (Toll
Free) sopan.gedam_at_databridgemarketresearch.com